These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 4901874)
1. [Present status of anti-lymphocyte serum and its problems]. Fujimoto Y Geka Chiryo; 1969 Jul; 21(1):86-91. PubMed ID: 4901874 [No Abstract] [Full Text] [Related]
3. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation. Cerilli GJ; Miller A; Hattan D Surg Forum; 1970; 21():250-2. PubMed ID: 4936976 [No Abstract] [Full Text] [Related]
4. [Antilymphocyte serum]. van Bekkum DW Ned Tijdschr Geneeskd; 1969 Jan; 113(1):22-8. PubMed ID: 4973960 [No Abstract] [Full Text] [Related]
5. Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes. Mauel J; Rudolf H; Chapuis B; Brunner KT Immunology; 1970 Apr; 18(4):517-35. PubMed ID: 5421033 [TBL] [Abstract][Full Text] [Related]
6. Preparation of an effective heterologous anti-lymphocyte serum for use in the dog. Atai M; Kelly WD Surg Forum; 1966; 17():249-51. PubMed ID: 5331815 [No Abstract] [Full Text] [Related]
8. Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Jooste SV; Lance EM; Levey RH; Medawar PB; Ruszkiewicz M; Sharman R; Taub RN Immunology; 1968 Nov; 15(5):697-705. PubMed ID: 4880356 [TBL] [Abstract][Full Text] [Related]
9. Experimental and clinical use of antilymphocytic serum in kidney transplantation. Zühlke V; Marchioro TL; Starzi TE Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; ():Suppl:469-76. PubMed ID: 4896594 [No Abstract] [Full Text] [Related]
10. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum. Waltman SR; Burde RM; Faulkner HW Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328 [No Abstract] [Full Text] [Related]
11. Lymphocytes and antilymphocytic serum. Woodruff M Endeavour; 1969 May; 28(104):65-7. PubMed ID: 4183771 [No Abstract] [Full Text] [Related]
12. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Monaco AP; Wood ML Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696 [No Abstract] [Full Text] [Related]
13. [Immunosuppressive properties of heterologous antilymphocyte sera (review of the literature)]. Khundanov LL; Portnoĭ VF; Kipervasser EM; Shatalova IN Eksp Khir Anesteziol; 1969; 14(2):41-6. PubMed ID: 4391647 [No Abstract] [Full Text] [Related]
14. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma. Jeejeebhoy HF Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509 [No Abstract] [Full Text] [Related]
15. [Experiences with heterologous antilymphocyte serums in man]. Pichlmayr R; Brendel W; Zenker R Munch Med Wochenschr; 1968 Apr; 110(15):893-8. PubMed ID: 4892058 [No Abstract] [Full Text] [Related]
16. Use of anti-lymphocyte serum to prolong renal allograft survival in dogs. Fujimoto Y; Miura T; Uchida H; Inou T Jpn J Exp Med; 1967 Jun; 37(3):205-16. PubMed ID: 4869985 [No Abstract] [Full Text] [Related]
17. [Heterologous antilymphocyte serum and its use]. Jasser S Pol Tyg Lek; 1970 May; 25(18):663-6. PubMed ID: 4393723 [No Abstract] [Full Text] [Related]
19. The place of heterologous antilymphocytic globulin in renal transplantation. Clunie GJ Med J Aust; 1969 Jun; 1(26):1368-70. PubMed ID: 4898052 [No Abstract] [Full Text] [Related]
20. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity. Monaco AP; Franco DJ Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263 [No Abstract] [Full Text] [Related] [Next] [New Search]